Loading...
HomeMy WebLinkAbout1 WHO Vanadium Guidance_20170726Chapter 6.12 General Description Vanadium Vanadium (V) is a bright white ductile metal belonging to group V of the periodic system of elements. It forms compounds mainly in valence states +3, +4 and +5. In the presence of oxygen, air or oxygenated blood, or oxidizing agents, vanadium is always in the +5 oxidation state. In the presence of reducing agents, vanadium compounds are in the +4 oxidation state (1). Vanadium forms both cationic and anionic salts, and can form covalent bonds to yield organometallic compounds which are mostly unstable. Sources Vanadium is an ubiquitous metal. The average concentration of vanadium in the earth's crust is 150 µg/g (2); concentrations in soil vary in the range 3-310 µg/g (3) and may reach high values (up to 400 µg/g) in areas polluted by fly ash (4). The concentration of vanadium in water is largely dependent on geographical location and ranges from 0.2 to more than 100 µg/litre in freshwater (2), and from 0.2 to 29 µg/litre in seawater (3). The ocean floor is the main long-term sink of vanadium in the global circulation (4). The concentrations of vanadium in coal and crude petroleum oils vary widely (1-1500 mg/kg) (2). The world production of vanadium was about 35 000 tonnes in 1981 (S), the major producing countries being Chile, Finland, Namibia, Norway, South Africa, USSR and the United States. Most of the vanadium produced is used in ferrovanadiurn and, of this, the majority is used in high-speed and other alloy steel (usually combined with chromium, nickel, manganese, boron and tungsten). It has been estimated that around 65 000 tonnes of vanadium annually enter the environment from natural sources (crustal weathering and volcanic emissions) and around 200 000 tonnes as a result of man's activities (6). The major anthropogenic point sources of atmospheric emission are metallurgical works (30 kg per tonne of vanadium produced), followed by the burning of crude or residual oil and coal (0.2-2 kg per 1000 tonnes and 30- 300 kg per 106 litres) (7). Global vanadium emissions into the atmosphere from coal combustion in 1968 were estimated to range from 1730 to 3760 tonnes. The contribution of vanadium to the atmosphere from residual -fuel combustion was estimated at 12 400-19 000 tonnes in 1969 and 14 000-22 000 tonnes in 1970. In the production of ferrovanadiurn for alloy additions in steel -making, vanadium emission to the atmosphere was estimated at 144 tonnes in 1968 (2). The burning of wood, other vegetable matter and solid wastes probably does not result in significant vanadium emission. In 1972, about 94% of all anthropogenic emissions of vanadium to the atmosphere in Canada (2065 tonnes) resulted from the combustion of fuel oil and only 1.2% from metallurgical industries (8). Occurrence in air Currently the ambient air levels of vanadium are quite low, but it is suspected that air concentrations will increase in the future as a function of accelerated fossil -fuel combustion in rural areas. Concentrations vary from tenths of nanograms to a few nanograms. In the air of big cities the annual average was between 50 and 100 ng/m3 (8,9) with significant seasonal variations © WHO Regional Office for Europe, Copenhagen, Denmark, 2000 Chapter 6.12 Vanadium Air Quality Guidelines - Second Edition (winter averages are more than three times the summer averages). More recent data from a five-year study in four Belgian cities show yearly averages of 41-179 ng/m3 (10). A recent survey of measurements in Member States of the European Community indicates the following concentration ranges: remote areas, 0.001-3 ng/m3; urban areas, 7-200 ng/m3; industrial areas, 10-70 ng/m3 (11). Concentrations up to 2 µg/m3 have been reported in several cities in the northeastern USA. A marked decline of vanadium concentration in ambient air was reported after the introduction of low -sulfur fuels (4). Air pollution by industrial plants may be less than that by power stations and heating equipment. The average concentration in the area surrounding a steel -plant site in Pennsylvania, USA, was 72 ng/m3 (2). Vanadium pentoxide (V205) was detected near a large metallurgical works in concentrations ranging from 0.98 to 1.49 µg/m3 in 87% of samples and exceeding 2 µg/m3 in 11 % of samples (12). With combustion of the carbonaceous matrix, vanadium is released to the atmosphere as fine fly ash with a long atmospheric residence time. Vanadium concentrates on the surface of particulate matter from coal combustion. The concentration of vanadium in fly ash from residual fuel -oil burning averages around 8% (range 2-18%), representing 56% (39-74%) of the vanadium concentration in fuel. The soluble fraction of fly ash vanadium averages 70% (42-96%). About 80% of the vanadium -containing particles have a mass median aerodynamic diameter smaller than 0.5 µm at the chimney, representing 10-20% of the total aerosol mass of vanadium (13). A large number of occupations involve exposure to vanadium. Concentrations in the working environment range from 0.01 to 30 mg/m3 (14), with varying particle distribution patterns and different degrees of solubility for different vanadium compounds. Very high levels of vanadium in the air were reported in boiler cleaning (17-60 mg/m) (15). Routes of Exposure Air Concentrations of airborne vanadium have increased in recent years, probably because of the increasing direct combustion of crude oil residues in power plants and community -heating systems. The average annual values for urban areas are reported to be in the range of 0.05- 0.18 µg/m3. Maximum concentrations of vanadium as high as 2 µg/m3 occur in areas of greatest population density, during the coldest part of the year and during the late evening hours. Drinking -water Concentrations of vanadium in drinking -water may range from about 0.2 to more than 100 µg/litre (16); typical values appear to be between 1 and 6 µg/litre (8). The concentration of vanadium in drinking -water depends significantly on geographical location. Food The few data on vanadium concentrations in food vary considerably; this may be explained by differences in the food itself and in the analytical methods used. The mean vanadium concentration in the diet was reported to be 32 µg/kg (range 19-50 µg) (17) and the mean daily intake was estimated to be 20 µg/day (18). Byrne & Kosta (19) estimated that the daily dietary intake of vanadium amounts to several tens of micrograms. The concentration of vanadium in human milk was found to be 0.1-0.2 ng/g (18). An infant drinking one litre of human milk per day would thus have a daily vanadium intake of 0.1-0.2 µg (8). © WHO Regional Office for Europe, Copenhagen, Denmark, 2000 2 Chapter 6.12 Vanadium Air Quality Guidelines - Second Edition Relative significance of different routes of exposure According to a pathway analysis (8), an individual living in a rural environment (assumed air concentration 8 ng vanadium per m3) will have a body -burden of around 100 µg, over 80% of which is derived from the diet; an urban dweller (assumed air concentration 70 ng/m) will have a total body -burden of around 200 µg (in the latter case, the inhalation route contributes approximately one half of the total burden). It was estimated that the daily intake by ingestion is about 20 µg and by inhalation 1.5 µg in an urban area and 0.2 µg in a rural area (8). Kinetics and Metabolism Absorption The lungs are a significant site of entry of vanadium in the case of community exposure. The distribution pattern of particles and the solubility of vanadium compounds, as well as alveolar and mucociliar clearance, are important factors that determine the rate of absorption in the respiratory tract. Moreover, the irritative effect of vanadium compounds can significantly modify the absorption of vanadium by the lungs. Vanadium accumulates in the human lung with age, reaching approximately 6.5 µg/g in the over-65 years age group (3). The lung clearance of vanadium pentoxide is relatively rapid in animals after acute exposure, but substantially slower after chronic exposure. The metal is deposited in the lung in relatively insoluble forms. Soluble compounds are partly absorbed, but the extent of absorption in the respiratory tract has not been determined. The absorption rate of vanadium compounds after ingestion depends on their solubility and chemical nature. Absorption of cationic vanadium is low, not exceeding 0.1-1% (8). Skin is probably a minor route of absorption in man (9). Distribution Absorbed vanadium is transported mainly in the plasma, bound to transferrin. The average value for the distribution of blood vanadium between plasma and cells in rats after an intravenous injection of 0.9-30 µg vanadium per kg was found to be 9 : 1 (20). Pentavalent vanadium is reduced in erythrocytes to the tetravalent form. This reduction is a glutathione- dependent process (21). Byrne & Kosta (19) reported blood vanadium levels in healthy individuals of below 0.5 µg/litre. The analytical method used was neutron activation analysis with pre -separation of vanadium. Vanadium is widely distributed in body tissues; principle organs of vanadium retention are kidneys, liver, testicles, spleen and bones. A major fraction of vanadium from cellular vanadium was found retained in nuclei (22). In pregnant rats the injected vanadium was found in the fetus (23). Elimination Vanadium is excreted mainly in the urine, but also in the faeces. Bile is probably not an important pathway for excretion into the faeces, but the existence of alternative routes for excretion into the gut (salivary excretion or direct transfer across the intestinal wall) has been suggested (20). When 4.5-9.0 mg vanadium as diammonium oxytetravanadate was fed daily to 16 elderly persons, urinary excretion, although quite variable, amounted to a mean of 5.2% of the amount ingested (24). © WHO Regional Office for Europe, Copenhagen, Denmark, 2000 3 Chapter 6.12 Vanadium Air Quality Guidelines - Second Edition Health Effects Nutritional studies have shown that vanadium is an essential element for the chick and rat (3). Its deficiency may result in growth reduction, impairment of reproduction and disturbances in lipid metabolism. Vanadium is also essential for soil nitrogen -fixing microorganisms (3). It may play a significant role in human nutrition (2). Biochemical, physiological and pharmacological properties of vanadium compounds have been reviewed (1,25). It has been suggested that vanadium may be a regulatory agent for enzymatic activities in mammalian tissues. Vanadium is a potent inhibitor of many enzymes, while it stimulates adenylate cyclase. It has been shown to inhibit cholesterol biosynthesis and lower plasma cholesterol levels. Vanadium can also directly influence glucose metabolism in vitro and may play a role in its regulation. Lipid peroxidation of rat lung extracts, liver microsomes and mitochondria was induced by sulfite and accelerated by the presence of vanadium compounds. Vanadium may play a physiological role as part of a control on levels of the endogenous antioxidant, glutathione. This may also be important with respect to toxic interactions of chemicals (26). Effects on experimental animals The toxicity of vanadium has been found to be high when it is given parenterally, low when it is orally administered, and intermediate in the case of respiratory exposure. Toxicity is related to the valency of the vanadium compound (increasing with increasing valency). Vanadium is toxic both as a cation and as an anion (16,27). Severe acute exposure (tens of mg/m3) is responsible for systemic effects. Most frequent findings in animal experiments were in the liver, kidneys, gonads and the nervous, haematological and cardiovascular systems (2, 3,16). However, systemic effects at very low levels of exposure were also reported (28). When rats were continuously exposed to an aerosol of vanadium pentoxide at levels of 6 and 27 µg/m3 (3.4-15 µg vanadium per in), neurotoxic effects appeared 30 days from the start of exposure. Measured chronaxy ratio between the flexor and extensor muscles of the tibia returned to normal about 18 days following cessation of exposure. Histopathological changes observed in the liver following the higher level of inhalation exposure (27 µg/m3 for 70 days) included central vein congestion with scattered small haemorrhages, and granular degeneration of hepatocytes. The kidneys showed marked granular degeneration of the epithelium of the convoluted tubules. In the heart, myocardial vascular congestion was observed, with focal perivascular haemorrhages. Numerous studies reported acute or chronic respiratory effects in laboratory animals following exposure to different vanadium compounds. Respiratory effects in rats at relatively low levels of vanadium pentoxide aerosol (3-5 mg/m3) for 2 hours every other day for 3 months, included perivascular oedema, capillary congestion, haemorrhages, and in some cases desquamative bronchitis or pneumonia (29). Similar effects were also observed at much lower levels. Rats exposed to vanadium pentoxide aerosol of 27 µg/m3 for 70 days developed different respiratory effects, such as marked lung congestion, focal lung haemorrhages and extensive bronchitis (28). Exposure to 2 µg vanadium pentoxide per m3 was considered to be without effect. Exposure to vanadium oxides may alter alveolar macrophage integrity and function to the detriment of pulmonary defence. Cytotoxicity, tested on rabbit alveolar macrophages in vitro, was directly related to solubility in the order V205 > V203 > V02. Dissolved vanadium pentoxide (6 µg/ml) also reduced phagocytosis (3). The effect of vanadium compounds on the function of alveolar macrophages may result in an impairment of the lung's resistance to © WHO Regional Office for Europe, Copenhagen, Denmark, 2000 4 Chapter 6.12 Vanadium Air Quality Guidelines - Second Edition secondary bacterial infection. It has been stated that VOC12 is a mutagen for Escherichia coli and VOC12, V205, NH4VO3 are capable of damaging DNA (30). There is no information that vanadium compounds have embryotoxic, teratogenic and carcinogenic effects. Effects on humans Both acute and chronic poisonings have been described in workers engaged in the industrial production and use of vanadium. Most of the reported clinical symptoms reflect irritative effects of vanadium on the respiratory There is insufficient evidence that vanadium causes generalized systemic effects except at extremely high concentrations (3). Several observers described only vague, general signs or symptoms and reported nervous disturbances, neurasthenic or vegetative symptoms, occasionally tremors, palpitation of the heart, high incidence of extrasystoles, changes in the blood picture (anaemia, leukopenia, punctatebasophilia of the erythrocytes), reduced level of cholesterol in the blood, etc. (16). Numerous studies have reported acute and chronic respiratory effects mainly due to exposure to vanadium pentoxide (2,3,16). Most of the reported clinical symptoms reflect irritative effects of vanadium on the upper respiratory tract. Only at high concentrations (above 1 mg vanadium per m3) were more serious effects of the lower respiratory tract observed, such as bronchitis and pneumonitis. Respiratory effects after acute or chronic expo- sure to low levels of vanadium are summarized in Table 1. Acute changes in lung function in workers exposed to vanadium compounds during cleaning of boilers were reported (time -weighted average concentration of respirable dust 523 µg/m3, 15.3% of vanadium, giving a value of 80 µg vanadium per m3) (31). In spite of the fact that the workers wore respirators, the changes in lung function developed within 24 hours and pre -exposure levels had not returned by the eighth day; however, the efficacy of the respirators was low (about 9% leakage). Respiratory effects after acute exposure to vanadium pentoxide dust were also observed in a clinical study in which healthy volunteers were exposed to levels of 100, 200 and 1000 µg vanadium pentoxide per in for 8 hours (32). It was found that 98% of the particles were smaller than 5 µm. Coughing, which persisted for several days, was the most characteristic symptom at all three levels of exposure. Chronic inhalation of vanadium pentoxide dusts in industry has resulted in rhinitis, pharyngitis, bronchitis, chronic productive cough, wheezing, shortness of breath and fatigue. Pneumonitis and bronchopneumonitis have also been observed (2, 3,16). It has been reported that vanadium workers are more susceptible to colds and other respiratory illnesses than others. Respiratory effects after chronic exposure to vanadium pentoxide were described in refinery workers (33) at an average level of 300 µg vanadium per m3 and at a maximum concentration of about 1 mg vanadium per in (92% of the particles were smaller than 0.5 µm). In comparison to controls, a statistically significant higher incidence of symptoms, described as cough with sputum production, eye, nose and throat irritation, injected pharynx and green tongue were reported. In workers exposed for several months to vanadium -containing dust in the range of 10-40 µg vanadium per in (concentrations were previously higher, 200-500 µg vanadium per m3), a macroscopic and microscopic survey of the upper respiratory tract of 63 males was performed (34). The results were compared with a control group of workers exposed to inert dust only, and matched for age and smoking habits. Microscopic examination of nasal smears revealed a statistically significant increase in neutrophils, and biopsies of nasal mucosa showed significantly elevated numbers of plasma and round cells. The histological picture © WHO Regional Office for Europe, Copenhagen, Denmark, 2000 5 Chapter 6.12 Vanadium Air Quality Guidelines - Second Edition was characteristic for an irritating effect of vanadium dust on the mucous membranes seen earlier in exposed laboratory animals. One study described a significant incidence (58%) of injected pharynx in workers engaged in the refining of vanadium pentoxide from soot generated by the combustion of heavy fuel -oil (35). Concentrations of vanadium in the air at various locations in the work environment were all less than 400 µg/m3, with mean values of 1.2-12.0 µg/m3. Vanadium compounds appear to be capable of inducing asthma bronchiale in previously nonatopic subjects and continuing manifestations of asthmatic symptoms were reported 8 weeks after subjects had left the industry (vanadium pentoxide refinery) (36). Some epidemiological data have shown positive correlations between the vanadium content of urban air and mortality from bronchitis, pneumonia, nephritis, cancer (other than lung cancer in males) (37) and "heart disease" (38). However, these analyses did not take into account important, probably relevant, factors such as exposure to other chemicals, smoking habits, etc. (16). In addition, most of these causes of excess mortality have not been reported in workers occupationally exposed to vanadium compounds (3). Evaluation of Human Health Risks Exposure The natural background level of vanadium in air has been reported to range from 0.02 to 1.9 ng/m3 in Canada (2). Vanadium concentrations recorded in rural areas varied from a few nanograms to tenths of a nanogram per m3, and in urban areas from 50 to 200 ng/m3. In big cities during winter, when high -vanadium fuel -oil was used for heating purposes, concentrations as high as 2000 ng/m3 have been reported. Air pollution by industrial plants may be less than that caused by power stations and heating equipment. The concentrations of vanadium in workplace air (0.01-60 mg/m3) are much higher than in the general environment. Health risk evaluation The acute and chronic effects of vanadium exposure on the respiratory system of occupationally exposed workers should be regarded as the most significant factors when establishing air quality guidelines. Most of the clinical symptoms reported reflect irritative effects of vanadium on the upper respiratory tract, except at higher concentrations (above 1 mg vanadium per m3), when more serious effects on the lower respiratory tract are observed. Clinical symptoms of acute exposure are reported (31) in workers exposed to concentrations ranging from 80 µg/m3 to several mg vanadium per m3, and in healthy volunteers (32) exposed to concentrations of 56-560 µg vanadium per m3 (Table 1). A study of occupationally exposed groups provides data reasonably consistent with those obtained from controlled acute human exposure experiments, suggesting that the lowest - observed -adverse -effect level for acute exposure can be considered to be 60 µg vanadium per In Chronic exposure to vanadium compounds revealed a continuum in the respiratory effects, ranging from slight changes in the upper respiratory tract, with irritation, coughing and injection of pharynx, detectable at 20 µg vanadium per m3, to more serious effects such as chronic bronchitis and pneumonitis, which occurred at levels above 1 mg/m3. Occupational studies illustrate the concentration -effect relationship at low levels of exposure (33-35), showing increased prevalence of irritative symptoms of the upper respiratory tract; this suggests that 20 µg vanadium per m3 can be regarded as the lowest -observed -adverse -effect level for chronic exposure (Table 1). There are no conclusive data on the health effects of © WHO Regional Office for Europe, Copenhagen, Denmark, 2000 6 Chapter 6.12 Vanadium Air Quality Guidelines - Second Edition exposure to airborne vanadium at present concentrations in the general population, and a sus- ceptible subpopulation is not known. However, vanadium is a potent respiratory irritant, which would suggest that asthmatics should be considered a special group at risk. There are no well documented animal data to support findings in human studies, although one study reported systemic and local respiratory effects in rats at levels of 3.4-15 µg/m3 (28). Guidelines Available data from occupational studies suggest that the lowest -observed -adverse -effect level of vanadium can be assumed to be 20 µg/m3, based on chronic upper respiratory tract symptoms. Since the adverse nature of the observed effects on the upper respiratory tract were minimal at this concentration and a susceptible subpopulation has not been identified, a protection factor of 20 was selected. It is believed that below 1 µg/m3 (averaging time 24 hours) environmental exposure to vanadium is not likely to have adverse effects on health. The available evidence indicates that the current vanadium levels generally found in industrialized countries are not in the range associated with potentially harmful effects. Table 1. Respiratory effects after acute and chronic exposures to low levels of vanadium Type of exposure Vanadium Concentration in µg/m Symptoms Reference compound Compound Vanadium Acute Boiler cleaning V205 523 80 Changes in parameters of lung (31) V203 functions Clinical study V205 1000 560 Respiratory irritation: (32) (experimental 8- persistent and frequent cough, hour exposure) expiratory wheezes V205 200 112 Persistent cough (7- 10 days) V205 100 56 Slight cough for 4 days Chronic Vanadium refinery V205 536 300 Respiratory irritation: cough, (33) sputum, nose and throat irritation, injected pharynx Vanadium refinery V205 18-71 10-40 Irritative changes of mucous (34) membranes of upper respiratory tract Vanadium V205 1.2-12.0 Respiratory irritation: injected (35) processing V203 pharynx References 1. Erdmann, E. et al. Vanadate and its significance in biochemistry and pharmacology. Biochemical pharmacology, 33: 945-950 (1984). 2. Committee on Biologic Effects of Atmospheric Pollutants. Vanadium. Washington, DC, National Academy of Sciences, 1974. 3. Waters, M.D. Toxicology of vanadium. In: Goyer, R.A. & Mehlman, M.A., ed. Advances in modern toxicology. Vol. 2. Toxicology of trace elements. New York, Wiley, 1977, pp. 147-189. 4. Bengtsson, S. & Tyler, G. Vanadium in the environment. London, University of London © WHO Regional Office for Europe, Copenhagen, Denmark, 2000 7 Chapter 6.12 Vanadium Air Quality Guidelines - Second Edition Monitoring and Assessment Research Centre, 1976 (MARC Report No. 2). 5. Mineral commodity summaries. Washington, DC, US Department of the Interior, Bureau of Mines, Division of Ferrous Metals, 1983. 6. Galloway, J.N. et al., ed. Toxic substances in atmospheric deposition: a review and assessment. 1980 (National Atmospheric Deposition Program Report NC- 141). 7. Anderson, D. Emission factors for trace substances. Research Triangle Park, NC, US Environmental Protection Agency, 1973 (Report No. EPA-450/2-73-001). 8. Davies, D.J.A. & Bennett, B.G. Exposure commitment assessments of environmental pollutants. London, University of London Monitoring Assessment and Research Centre, 1983, Vol. 3 (MARC Report No. 30). 9. Scientific and technical assessment report on vanadium. Washington, DC, US Environmental Protection Agency, 1977 (Report No. EPA-600/6-77-002). 10. Kretzschmar, J.D. et al. Heavy metal levels in Belgium: a five-year survey. Science of the total environment, 14: 85-97 (1980). 11. Lahmann, E. et al. Heavy metals: identification of air quality and environmental problems in the European Community. Luxembourg, Commission of the European Communities, 1986, Vol. 1 & 2 (Report No. EUR 10678 EN/I and EUR 10678 EN/II). 12. Paznych, V.M. In: [Hygiene of population aggregates]. Kiev, 1977, pp. 99-100 (Republican interagency collected volume) (in Russian). 13. Aboulafia, J. et al. Emissions de vanadium par les installations thermiques des raffineries de p6trole [Vanadium emissions from thermal installations of petroleum refineries]. Pollution atmospherique, 101: 13-20 (1984). 14. Roscin, LV. [Vanadium and its compounds]. Moscow, Medicina, 1968, pp. 139-146 (in Russian). 15. Williams, N. Vanadium poisoning from cleaning oil -fired boilers. British journal of industrial medicine, 9: 50-55 (1952). 16. Vouk, V. Vanadium. In: Friberg, L. et al., ed. Handbook on the toxicology of metals. Amsterdam, Elsevier -North Holland Biomedical Press, 1979, pp. 659-674. 17. Myron, D.R. et al. Vanadium content of selected foods as determined by flameless atomic absorption spectroscopy. Journal of agricultural and food chemistry, 25: 297-300 (1977). 18. Myron, D.R. et al. Intake of nickel and vanadium by humans. A survey of selected diets. American journal of clinical nutrition, 31: 527-531 (1978). 19. Byrne, A.R. & Kosta, L. Vanadium in foods and in human body fluids and tissues. Science of the total environment, 10: 17-30 (1978). 20. Sabbioni, E. et al. Biliary excretion of vanadium in rats. Toxicological European research, 3: 93-98 (1981). 21. Hansen, T.V. et al. The effect of chelating agents on vanadium distribution in the rat body and on uptake by human erythrocytes. Archives of toxicology, 50: 195-202 (1982). 22. Sabbioni, E. & Marafante, E. Metabolic patterns of vanadium in the rat. Bioinorganic chemistry, 9: 389-407 (1978). 23. Soremark, R. et al. Autoradiographic localization of V-48-labelled vanadium pentoxide (V205) in developing teeth and bones in rats. Acta odontologica scandinavica, 20: 225- 232 (1962). 24. Tipton, I.H. et al. Patterns of elemental excretion in long-term balance studies. Health physics, 16: 455-462 (1969). 25. Jaudhyala, B.S. & Hom, G.L. Physiological and pharmacological properties of vanadium. Life sciences, 33: 1325-1340 (1983). 26. Stacey, N.H. & Klaassen, C.D. Inhibition of lipid peroxidation without prevention of cellular injury in isolated rat hepatocytes. Toxicology and applied pharmacology, 58: 8-18 © WHO Regional Office for Europe, Copenhagen, Denmark, 2000 8 Chapter 6.12 Vanadium Air Quality Guidelines - Second Edition (1981). 27. Venugopal, B. & Luckey, T.D. Metal toxicity in mammals. 2. Chemical toxicity of metals and metalloids. New York, Plenum Press, 1978, pp. 220-226. 28. Paznych, V.M. [Maximum permissible concentration of vanadium pentoxide in the atmosphere]. Gigiena i sanitarija, 31: 6-12 (1966) (in Russian). 29. Roscin, LV. Vanadium. In: Izraelson, Z.I., ed. Toxicology of the rare metals. Jerusalem, Israel Program for Scientific Translations, 1967, pp. 52-59 (AEC-tr-6710). 30. Kanematsu, N. & Kada, T. Mutagenicity of metal compounds. Mutation research, 54: 215-216 (1978). 31. Lees, R.E.M. Changes in lung function after exposure to vanadium compounds in fuel oil ash. British journal of industrial medicine, 37: 253-256 (1980). 32. Zenz, C. & Berg, B.A. Human responses to controlled vanadium pentoxide exposure. Archives of environmental health, 14: 709-712 (1967). 33. Lewis, C.E. The biological effects of vanadium. IL The signs and symptoms of occupational vanadium exposure. AMA archives of industrial health, 19: 497-503 (1959). 34. Kiviluoto, M. et al. Effects of vanadium on the upper respiratory tract of workers in a vanadium factory. Scandinavian journal of work, environment & health, 5: 50-58 (1979). 35. Nishiyama, K. et al. [A survey of workers on vanadium pentoxide]. Shikoku igaku zasshi, 31: 389-393 (1977) (in Japanese). 36. Musk, A.W. & Tees, J.G. Asthma caused by occupational exposure to vanadium compounds. Medical journal of Australia, 1:183-184 (1982). 37. Stocks, P. On the relations between atmospheric pollution in urban and rural localities and mortality from cancer, bronchitis and pneumonia, with particular reference to 3,4- benzopyrene, beryllium, molybdenum, vanadium and arsenic. British journal of cancer, 14: 397-418 (1960). 38. Hickey, R.J. et al. Relationship between air pollution and certain chronic disease death rates - multivariate statistical studies. Archives of environmental health, 15: 728-738 (1967). © WHO Regional Office for Europe, Copenhagen, Denmark, 2000 9